We present a CRISPR-Cas based technique for deleting genes from the T7 bacteriophage genome. A DNA fragment encoding homologous arms to the target gene to be deleted is first cloned into a plasmid. The T7 phage is then propagated in Escherichia coli harboring this plasmid. During this propagation, some phage genomes undergo homologous recombination with the plasmid, thus deleting the targeted gene. To select for these genomes, the CRISPR-Cas system is used to cleave non-edited genomes, enabling isolation of the desired recombinant phages. This protocol allows seamless deletion of desired genes in a T7 phage, and can be expanded to other phages and other types of genetic manipulations as well.
Construction of pAnti-GeneX
This plasmid encodes specific spacers that will serve to target the unmodified phage, thus enabling selection of the modified phage.
a. Perform a PCR amplification reaction with pWUR477 plasmid as a template using primers with 5' overhangs that form a new spacer upon ligation. See Figure 2 below. 9. Pre-warm LB agar plates with the antibiotics prepared in step C3 for at least 1 h at 37 °C. Table 1 ), mix in a 15 ml tube: 100 µl bacteria (from step C7). 13. Dilute 1:50 targeting bacteria into 5 ml LB supplemented with 50 µg/ml streptomycin, 50 µg/ml kanamycin and 35 µg/ml chloramphenicol, 0.2% L-arabinose and 0.1 mM IPTG.
For every combination of phage and bacteria (see
14. Shake at 37 °C to an OD600 ~0.5.
15. Infect the culture with 10 µl of the validated engineered phage. 16 . Shake the infected bacteria at 37 °C until lysis occurs (usually 2 h). 
